DGAP-News: M1 Kliniken AG / Key word(s): Change of Personnel
M1 Kliniken AG strengthens management team - Dr. Walter von Horstig appointed to the Management Board

27.09.2017 / 16:45
The issuer is solely responsible for the content of this announcement.


M1 Kliniken AG strengthens management team - Dr. Walter von Horstig appointed to the Management Board

M1 Kliniken AG announces that the company's Supervisory Board has appointed Dr. Walter von Horstig to the Management Board of the company effective October 1,2017. Together with Patrick Brenske, he will drive the further growth and development of the company.

Dr. von Horstig has studied business administration and has extensive experience in the healthcare industry. Since April 2017 he has been successfully working as managing director of M1 Med Beauty Berlin GmbH. Before that, for seven years he was managing director of a DRK Blood Donation Service and has led the company to renewed growth.

Dr. Albert Wahl, Chairman of the Supervisory Board of M1 Kliniken AG, comments on the decision as follows: "As a young and fast-growing company, M1 has to concentrate on the expansion of its own product and service offering with a focus on quality and efficiency for the benefit of patients. With Dr. von Horstig, we have found an ideal fit with profound industry knowledge."

Dr. von Horstig adds: "I am looking forward to the exciting task and the challenges of working with the M1 team to achieve the goals set by the company.

About M1 Kliniken AG:
M1 Kliniken AG is one of the fastest growing and leading private providers of healthcare services in the field of beauty medicine. With its products and services, the group offers a customer-oriented range of aesthetic and surgical treatments throughout Germany. Due to the experienced and highly specialized team of specialists and medical personnel, minimal invasive and surgical interventions are carried out with the highest quality standards using high-quality products and state-of-the-art medical technology. Furthermore, high-quality products are marketed to doctors, pharmacies and wholesalers.

Details of the shares of M1 Kliniken AG:
Subscribed capital: EUR 15,000,000
Share class: bearer shares
ISIN: DE000A0STSQ8 * WKN: A0STSQ * Exchange mark: M12
M1 Kliniken AG is listed on the Basic Board of the Frankfurt Stock Exchange.



27.09.2017 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: M1 Kliniken AG
Grünauer Straße 5
12557 Berlin
Germany
Phone: +49 (0)30 / 88 70 862-25
Fax: +49 (0)30 / 88 70 862-28
E-mail: ir@m1-kliniken.de
Internet:https://www.m1-kliniken.de
ISIN: DE000A0STSQ8
WKN: A0STSQ
Listed: Regulated Unofficial Market in Dusseldorf, Stuttgart; Open Market (Basic Board) in Frankfurt

 
End of News DGAP News Service

613613  27.09.2017 

fncls.ssp?fn=show_t_gif&application_id=613613&application_name=news&site_id=zonebourse